Epaminondas Doxakis, PhD, MBA, MSc

Epaminondas Doxakis is a Principal Investigator at the Biomedical Research Foundation of the Academy of Athens (BRFAA), where he leads a laboratory studying post-transcriptional regulation in Parkinson’s disease and related neurodegenerative disorders. He earned an MSc from Eötvös Loránd University and a PhD from the University of St Andrews, followed by postdoctoral training at the University of Edinburgh and the Cardiff School of Biosciences. His research examines SNCA mRNA regulation, RNA-binding protein biology, and non-coding RNAs, including miRNAs, circRNAs, and tRFs, with a focus on mechanisms shaping neuronal vulnerability. He develops antisense oligonucleotide strategies for Parkinson’s disease and pursues RNA-based biomarker discovery for Parkinsonian syndromes. He holds an MBA from Edinburgh Business School and coordinates international multi-site collaborations in neurodegeneration research.